Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9708320 β-lactamase inhibitor and process for preparing the same

Patent 9708320 was granted and assigned to Meiji Seika Pharma on July, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Meiji Seika Pharma

Current Assignee

Meiji Seika Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9708320

Patent Inventor Names

Takao Abe0

Yoshiaki Sakamaki0

Akihiro Morinaka0

Seiichi Inamura0

Takeshi Furuuchi0

Date of Patent

July 18, 2017

Patent Application Number

14872988

Date Filed

October 1, 2015

Patent Citations Received

‌

US Patent 12103928 Processes for preparing a diazabicyclooctane compound

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

A diazabicyclooctane compound, which is a beta-lactame inhibitor, represented by the following formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9708320 β-lactamase inhibitor and process for preparing the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API